SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-327303
Filing Date
2021-11-12
Accepted
2021-11-12 07:12:30
Documents
48
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d192385d10q.htm   iXBRL 10-Q 1727569
2 EX-31.1 d192385dex311.htm EX-31.1 10099
3 EX-31.2 d192385dex312.htm EX-31.2 10080
4 EX-32.1 d192385dex321.htm EX-32.1 6289
  Complete submission text file 0001193125-21-327303.txt   4672269

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cmpi-20210930.xsd EX-101.SCH 29395
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpi-20210930_cal.xml EX-101.CAL 28251
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpi-20210930_def.xml EX-101.DEF 169513
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpi-20210930_lab.xml EX-101.LAB 248159
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpi-20210930_pre.xml EX-101.PRE 208390
10 EXTRACTED XBRL INSTANCE DOCUMENT d192385d10q_htm.xml XML 484906
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39425 | Film No.: 211399516
SIC: 2836 Biological Products, (No Diagnostic Substances)